文献速递临床微生物质量管理与危急值

医疗相关感染防控压力升级:对临床微生物实验室的影响

Rising Stakes for Health Care-Associated Infection Prevention: Implications for the Clinical Microbiology Laboratory.
PubMed 文献 · J Clin Microbiol · 2017-01-25

本文综述了医疗相关感染(HAI)率与CMS报销挂钩后,临床微生物实验室(CML)检测技术进步可能提高HAI报告率,并探讨财务压力对诊断实践的影响及应对建议。

要点

  • HAI率与CMS报销挂钩,实验室检测进步可能提高报告率
  • 财务压力可能促使改变诊断检测实践
  • 需积极应对这一快速变化的环境

核心结论

  • 临床微生物实验室检测实践的变化可影响HAI报告率,财务压力可能促使改变诊断检测实践。

研究设计与样本

  • 综述,无系统检索范围报告。

主要发现

  • HAI率受公开报告并与CMS报销挂钩,实验室检测更精确敏感可能增加报告HAI率。

临床怎么用

  • 需关注实验室检测变化对HAI率的影响并应对财务压力下的诊断实践改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Health care-associated infection (HAI) rates are subject to public reporting and are linked to hospital reimbursement from the Centers for Medicare and Medicaid Services (CMS). The increasing pressure to lower HAI rates comes at a time when advances in the clinical microbiology laboratory (CML) provide more-precise and -sensitive tests, altering HAI detection in ways that may increase reported HAI rates. I review how changing CML practices can impact HAI rates and how the financial implications of HAI metrics may produce pressure to change diagnostic testing practices. Finally, I provide suggestions for how to respond to this rapidly changing environment.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Diekema DJ. Rising Stakes for Health Care-Associated Infection Prevention: Implications for the Clinical Microbiology Laboratory. J Clin Microbiol. 2017. PMID: 28122873. doi:10.1128/JCM.02544-16

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。